Friday, November 13, 2026
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Press releaseGlobeNewswire· March 26, 2026

CommodityHero Introduces TradeLens Platform to Expand Access to Historical Commodity Trade Data

View original at globenewswire.com
CommodityHero Introduces TradeLens Platform to Expand Access to Historical Commodity Trade Data Las Vegas, Nevada, March 26, 2026 (GLOBE NEWSWIRE) -- CommodityHero, a technology company operating within the commodity brokerage sector, announced the launch of TradeLens, a data platform designed to provide brokers with c…
Opening lines of the source · GlobeNewswire · short snapshot — read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • TradeLens reflects a continued effort to improve how brokers interact with data. The platform brings together a large volume of historical trade records into a single environment, making it easier to review and work with structured information.

    60% confidence
  • Our approach has been to ensure that data and tools exist within the same operational framework. TradeLens extends that framework by incorporating historical trade information directly into the platform.

    60% confidence
  • The company reported a 1000 percent increase in platform activity between 2024 and 2025, citing broader adoption of digital tools within commodity brokerage as a contributing element.

    60% confidence
  • Changes in how brokers access and use data have influenced the development of our platform. TradeLens is part of an ongoing effort to align with those changes by providing a centralized data resource.

    60% confidence
  • Providing access to well-organized data is a foundational step in supporting brokerage operations. TradeLens is intended to make that data easier to locate and review within a single system.

    60% confidence
  • Access to organized historical data has been a recurring need within the brokerage environment. TradeLens was developed to provide a structured way to view past transactions without requiring extensive manual compilation.

    60% confidence

Cited in these Via News reports

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Late-2026 Biotech Catalyst Season: FDA Decisions and Pivotal Readouts Converge Across Oncology, Hepatology and Cardiometabolic
Mid-November 2026 is dense with scheduled biotech catalysts. The ivonescimab BLA PDUFA date is 2026-11-14, the lorundrostat PDUFA date is 2026-12-22, and Phase 3 ECLIPSE hepatitis delta data are due in Q1 2027. Alongside these, siRNA and antibody programs (plozasiran, elebsiran/tobevibart, ianalumab, nipocalimab) reported or presented data at AHA, AASLD, ACR and ASH, while Oryzon advanced iadademstat in AML with Spanish trial authorizations and a planned ALICE-3 Phase III. Late-stage data and regulatory milestones are driving the sentiment. A planned delisting (EGM 2026-11-19, application 2027-01-25) is a separate corporate-structure event with no clear link to the rest.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,995
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,995 facts checked against source5,577 source documents archived
Query this data → isubstrate.com